The Clorox Company
NYSECLX enters its August 3 earnings print with the most negative analyst backdrop it has faced in months — and a short book that barely budged despite the stock holding flat on the week. The week's defining moment came from Jefferies, which downgraded CLX to Hold from Buy on July 28 and slashed its target from $125 to $98. That is a $27 cut from a firm that was, until days ago, one of…
CLX short interest surged 12% in one session to 7.44% of float, part of a 22% climb over the past week — the sharpest weekly increase since…
Snapshot as of 30 Aug 2026
CLX enters its August 3 earnings print with the most negative analyst backdrop it has faced in months — and a short book that barely budged despite the stock holding flat on the week. The week's defining moment came…
CLX reports its next quarterly results on August 3 with the analyst community shifting more negative in the final days before the print — a meaningful development given short positioning that was already elevated…
CLX heads into its July 31 earnings release with short sellers entrenched and options traders turning more defensive than they have been in months. Short positioning is meaningfully elevated. Bears hold 9.7% of the…
Clorox reports Q3 fiscal 2026 results tonight — and the setup heading in is notably more bearish than it was a month ago. Short sellers have rebuilt positions sharply. SI as a percentage of the free float climbed to…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CLX — free to start on ORTEX.
Sign up for free →Open CLX on ORTEX